APO Research
Talk to an analyst

APO RESEARCH · REPORT

Supplement for Menopause

Compare research editions
View pricing & licenses

Selected research

Industry Research

Supplement for Menopause Industry Research Report 2026

23 December 2025143 pages

Choose your research edition.

Industry ResearchSupplement for Menopause Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Supplement for Menopause Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Supplement for Menopause Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Supplement for Menopause Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Supplement for Menopause Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Supplement for Menopause market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Supplement for Menopause is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Supplement for Menopause is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Supplement for Menopause is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Supplement for Menopause include Vitabiotics, The Better Menopause, SMPNutra, Promensil, PhytoLife Pharma, PharmaLinea, Otsuka Pharmaceutical, Nordic Naturals and New Nordic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Supplement for Menopause market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Supplement for Menopause Market by Company

Vitabiotics

The Better Menopause

SMPNutra

Promensil

PhytoLife Pharma

PharmaLinea

Otsuka Pharmaceutical

Nordic Naturals

New Nordic

Menopace

MenoLabs

Menoelle

Makers Nutrition

Kobayashi Pharmaceutical

GNC

Flourish

Equelle

Bonafide Health

Biofarma Group

Amerifit Brands(Estroven)

AdvaCare Pharma

Supplement for Menopause Segment by Type

Cardiovascular and Metabolic Support Supplements

Mood and Sleep Regulation Supplements

Hormone Regulation Supplements

Bone Health Supplements

Others

Supplement for Menopause Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital

Supplement for Menopause Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Supplement for Menopause market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Supplement for Menopause and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Supplement for Menopause.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Supplement for Menopause manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Supplement for Menopause by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Supplement for Menopause in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Supplement for Menopause Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Supplement for Menopause Sales (k units) of Manufacturers (2021-2026) Table 7. Global Supplement for Menopause Sales Market Share by Manufacturers (2021-2026) Table 8. Global Supplement for Menopause Revenue of Manufacturers (2021-2026) Table 9. Global Supplement for Menopause Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Supplement for Menopause Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Supplement for Menopause Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Supplement for Menopause, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Supplement for Menopause, Product Type & Application Table 14. Global Supplement for Menopause Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Supplement for Menopause by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Vitabiotics Company Information Table 19. Vitabiotics Business Overview Table 20. Vitabiotics Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Vitabiotics Supplement for Menopause Product Portfolio Table 22. Vitabiotics Recent Developments Table 23. The Better Menopause Company Information Table 24. The Better Menopause Business Overview Table 25. The Better Menopause Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. The Better Menopause Supplement for Menopause Product Portfolio Table 27. The Better Menopause Recent Developments Table 28. SMPNutra Company Information Table 29. SMPNutra Business Overview Table 30. SMPNutra Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. SMPNutra Supplement for Menopause Product Portfolio Table 32. SMPNutra Recent Developments Table 33. Promensil Company Information Table 34. Promensil Business Overview Table 35. Promensil Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Promensil Supplement for Menopause Product Portfolio Table 37. Promensil Recent Developments Table 38. PhytoLife Pharma Company Information Table 39. PhytoLife Pharma Business Overview Table 40. PhytoLife Pharma Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. PhytoLife Pharma Supplement for Menopause Product Portfolio Table 42. PhytoLife Pharma Recent Developments Table 43. PharmaLinea Company Information Table 44. PharmaLinea Business Overview Table 45. PharmaLinea Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. PharmaLinea Supplement for Menopause Product Portfolio Table 47. PharmaLinea Recent Developments Table 48. Otsuka Pharmaceutical Company Information Table 49. Otsuka Pharmaceutical Business Overview Table 50. Otsuka Pharmaceutical Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Otsuka Pharmaceutical Supplement for Menopause Product Portfolio Table 52. Otsuka Pharmaceutical Recent Developments Table 53. Nordic Naturals Company Information Table 54. Nordic Naturals Business Overview Table 55. Nordic Naturals Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Nordic Naturals Supplement for Menopause Product Portfolio Table 57. Nordic Naturals Recent Developments Table 58. New Nordic Company Information Table 59. New Nordic Business Overview Table 60. New Nordic Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. New Nordic Supplement for Menopause Product Portfolio Table 62. New Nordic Recent Developments Table 63. Menopace Company Information Table 64. Menopace Business Overview Table 65. Menopace Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Menopace Supplement for Menopause Product Portfolio Table 67. Menopace Recent Developments Table 68. MenoLabs Company Information Table 69. MenoLabs Business Overview Table 70. MenoLabs Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. MenoLabs Supplement for Menopause Product Portfolio Table 72. MenoLabs Recent Developments Table 73. Menoelle Company Information Table 74. Menoelle Business Overview Table 75. Menoelle Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Menoelle Supplement for Menopause Product Portfolio Table 77. Menoelle Recent Developments Table 78. Makers Nutrition Company Information Table 79. Makers Nutrition Business Overview Table 80. Makers Nutrition Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Makers Nutrition Supplement for Menopause Product Portfolio Table 82. Makers Nutrition Recent Developments Table 83. Kobayashi Pharmaceutical Company Information Table 84. Kobayashi Pharmaceutical Business Overview Table 85. Kobayashi Pharmaceutical Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Kobayashi Pharmaceutical Supplement for Menopause Product Portfolio Table 87. Kobayashi Pharmaceutical Recent Developments Table 88. GNC Company Information Table 89. GNC Business Overview Table 90. GNC Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. GNC Supplement for Menopause Product Portfolio Table 92. GNC Recent Developments Table 93. Flourish Company Information Table 94. Flourish Business Overview Table 95. Flourish Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Flourish Supplement for Menopause Product Portfolio Table 97. Flourish Recent Developments Table 98. Equelle Company Information Table 99. Equelle Business Overview Table 100. Equelle Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Equelle Supplement for Menopause Product Portfolio Table 102. Equelle Recent Developments Table 103. Bonafide Health Company Information Table 104. Bonafide Health Business Overview Table 105. Bonafide Health Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Bonafide Health Supplement for Menopause Product Portfolio Table 107. Bonafide Health Recent Developments Table 108. Biofarma Group Company Information Table 109. Biofarma Group Business Overview Table 110. Biofarma Group Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Biofarma Group Supplement for Menopause Product Portfolio Table 112. Biofarma Group Recent Developments Table 113. Amerifit Brands(Estroven) Company Information Table 114. Amerifit Brands(Estroven) Business Overview Table 115. Amerifit Brands(Estroven) Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Amerifit Brands(Estroven) Supplement for Menopause Product Portfolio Table 117. Amerifit Brands(Estroven) Recent Developments Table 118. AdvaCare Pharma Company Information Table 119. AdvaCare Pharma Business Overview Table 120. AdvaCare Pharma Supplement for Menopause Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. AdvaCare Pharma Supplement for Menopause Product Portfolio Table 122. AdvaCare Pharma Recent Developments Table 123. Global Supplement for Menopause Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Supplement for Menopause Sales by Region (2021-2026) & (k units) Table 125. Global Supplement for Menopause Sales Market Share by Region (2021-2026) Table 126. Global Supplement for Menopause Sales by Region (2027-2032) & (k units) Table 127. Global Supplement for Menopause Sales Market Share by Region (2027-2032) Table 128. Global Supplement for Menopause Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Supplement for Menopause Revenue Market Share by Region (2021-2026) Table 130. Global Supplement for Menopause Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Supplement for Menopause Revenue Market Share by Region (2027-2032) Table 132. North America Supplement for Menopause Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Supplement for Menopause Sales by Country (2021-2026) & (k units) Table 134. North America Supplement for Menopause Sales by Country (2027-2032) & (k units) Table 135. North America Supplement for Menopause Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Supplement for Menopause Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Supplement for Menopause Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Supplement for Menopause Sales by Country (2021-2026) & (k units) Table 139. Europe Supplement for Menopause Sales by Country (2027-2032) & (k units) Table 140. Europe Supplement for Menopause Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Supplement for Menopause Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Supplement for Menopause Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Supplement for Menopause Sales by Country (2021-2026) & (k units) Table 144. Asia Pacific Supplement for Menopause Sales by Country (2027-2032) & (k units) Table 145. Asia Pacific Supplement for Menopause Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Supplement for Menopause Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Supplement for Menopause Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Supplement for Menopause Sales by Country (2021-2026) & (k units) Table 149. South America Supplement for Menopause Sales by Country (2027-2032) & (k units) Table 150. South America Supplement for Menopause Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Supplement for Menopause Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Supplement for Menopause Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Supplement for Menopause Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa Supplement for Menopause Sales by Country (2027-2032) & (k units) Table 155. Middle East and Africa Supplement for Menopause Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Supplement for Menopause Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Supplement for Menopause Sales by Type (2021-2026) & (k units) Table 158. Global Supplement for Menopause Sales by Type (2027-2032) & (k units) Table 159. Global Supplement for Menopause Sales Market Share by Type (2021-2026) Table 160. Global Supplement for Menopause Sales Market Share by Type (2027-2032) Table 161. Global Supplement for Menopause Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Supplement for Menopause Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Supplement for Menopause Revenue Market Share by Type (2021-2026) Table 164. Global Supplement for Menopause Revenue Market Share by Type (2027-2032) Table 165. Global Supplement for Menopause Price by Type (2021-2026) & (USD/unit) Table 166. Global Supplement for Menopause Price by Type (2027-2032) & (USD/unit) Table 167. Global Supplement for Menopause Sales by Application (2021-2026) & (k units) Table 168. Global Supplement for Menopause Sales by Application (2027-2032) & (k units) Table 169. Global Supplement for Menopause Sales Market Share by Application (2021-2026) Table 170. Global Supplement for Menopause Sales Market Share by Application (2027-2032) Table 171. Global Supplement for Menopause Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Supplement for Menopause Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Supplement for Menopause Revenue Market Share by Application (2021-2026) Table 174. Global Supplement for Menopause Revenue Market Share by Application (2027-2032) Table 175. Global Supplement for Menopause Price by Application (2021-2026) & (USD/unit) Table 176. Global Supplement for Menopause Price by Application (2027-2032) & (USD/unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Supplement for Menopause Distributors List Table 180. Supplement for Menopause Customers List Table 181. Supplement for Menopause Industry Trends Table 182. Supplement for Menopause Industry Drivers Table 183. Supplement for Menopause Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Supplement for Menopause Product Image Figure 5. Global Supplement for Menopause Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Supplement for Menopause Market Size (2021-2032) & (US$ Million) Figure 7. Global Supplement for Menopause Sales (2021-2032) & (k units) Figure 8. Global Supplement for Menopause Average Price (USD/unit) & (2021-2032) Figure 9. Cardiovascular and Metabolic Support Supplements Product Image Figure 10. Mood and Sleep Regulation Supplements Product Image Figure 11. Hormone Regulation Supplements Product Image Figure 12. Bone Health Supplements Product Image Figure 13. Others Product Image Figure 14. Retail Pharmacies Product Image Figure 15. Online Pharmacies Product Image Figure 16. Hospital Product Image Figure 17. Global Supplement for Menopause Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Supplement for Menopause, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Supplement for Menopause Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Supplement for Menopause Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Supplement for Menopause Sales by Region in 2025 Figure 23. Global Supplement for Menopause Revenue by Region in 2025 Figure 24. North America Supplement for Menopause Market Size by Country in 2025 Figure 25. North America Supplement for Menopause Sales Market Share by Country (2021-2032) Figure 26. North America Supplement for Menopause Revenue Market Share by Country (2021-2032) Figure 27. United States Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Supplement for Menopause Market Size by Country in 2025 Figure 31. Europe Supplement for Menopause Sales Market Share by Country (2021-2032) Figure 32. Europe Supplement for Menopause Revenue Market Share by Country (2021-2032) Figure 33. Germany Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Supplement for Menopause Market Size by Country in 2025 Figure 44. Asia Pacific Supplement for Menopause Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Supplement for Menopause Revenue Market Share by Country (2021-2032) Figure 46. China Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Supplement for Menopause Market Size by Country in 2025 Figure 55. South America Supplement for Menopause Sales Market Share by Country (2021-2032) Figure 56. South America Supplement for Menopause Revenue Market Share by Country (2021-2032) Figure 57. Brazil Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Supplement for Menopause Market Size by Country in 2025 Figure 61. Middle East and Africa Supplement for Menopause Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Supplement for Menopause Revenue Market Share by Country (2021-2032) Figure 63. Egypt Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Supplement for Menopause Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Supplement for Menopause Sales Market Share by Type (2021-2032) Figure 69. Global Supplement for Menopause Revenue Market Share by Type (2021-2032) Figure 70. Global Supplement for Menopause Price (USD/unit) by Type (2021-2032) Figure 71. Global Supplement for Menopause Sales Market Share by Application (2021-2032) Figure 72. Global Supplement for Menopause Revenue Market Share by Application (2021-2032) Figure 73. Global Supplement for Menopause Price (USD/unit) by Application (2021-2032) Figure 74. Supplement for Menopause Value Chain Figure 75. Supplement for Menopause Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Supplement for Menopause Industry Opportunities and Challenges

Scope & coverage.

Types
  • Cardiovascular and Metabolic Support Supplements
  • Mood and Sleep Regulation Supplements
  • Hormone Regulation Supplements
  • Bone Health Supplements
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital
Companies covered
  • Vitabiotics
  • The Better Menopause
  • SMPNutra
  • Promensil
  • PhytoLife Pharma
  • PharmaLinea
  • Otsuka Pharmaceutical
  • Nordic Naturals
  • New Nordic
  • Menopace
  • MenoLabs
  • Menoelle
  • Makers Nutrition
  • Kobayashi Pharmaceutical
  • GNC
  • Flourish
  • Equelle
  • Bonafide Health
  • Biofarma Group
  • Amerifit Brands(Estroven)
  • AdvaCare Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Supplement for Menopause Market Size (2021-2032)
  4. 2.2.2 Global Supplement for Menopause Sales (2021-2032)
  5. 2.2.3 Global Supplement for Menopause Market Average Price (2021-2032)
  6. 2.3 Supplement for Menopause by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Cardiovascular and Metabolic Support Supplements
  9. 2.3.3 Mood and Sleep Regulation Supplements
  10. 2.3.4 Hormone Regulation Supplements
  11. 2.3.5 Bone Health Supplements
  12. 2.3.6 Others
  13. 2.4 Supplement for Menopause by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Retail Pharmacies
  16. 2.4.3 Online Pharmacies
  17. 2.4.4 Hospital
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Supplement for Menopause Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Supplement for Menopause Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Supplement for Menopause Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Supplement for Menopause Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Supplement for Menopause Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Supplement for Menopause, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Supplement for Menopause, Product Type & Application
  8. 3.8 Global Manufacturers of Supplement for Menopause, Established Date
  9. 3.9 Global Supplement for Menopause Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Vitabiotics
  2. 4.1.1 Vitabiotics Company Information
  3. 4.1.2 Vitabiotics Business Overview
  4. 4.1.3 Vitabiotics Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Vitabiotics Supplement for Menopause Product Portfolio
  6. 4.1.5 Vitabiotics Recent Developments
  7. 4.2 The Better Menopause
  8. 4.2.1 The Better Menopause Company Information
  9. 4.2.2 The Better Menopause Business Overview
  10. 4.2.3 The Better Menopause Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 The Better Menopause Supplement for Menopause Product Portfolio
  12. 4.2.5 The Better Menopause Recent Developments
  13. 4.3 SMPNutra
  14. 4.3.1 SMPNutra Company Information
  15. 4.3.2 SMPNutra Business Overview
  16. 4.3.3 SMPNutra Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 SMPNutra Supplement for Menopause Product Portfolio
  18. 4.3.5 SMPNutra Recent Developments
  19. 4.4 Promensil
  20. 4.4.1 Promensil Company Information
  21. 4.4.2 Promensil Business Overview
  22. 4.4.3 Promensil Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Promensil Supplement for Menopause Product Portfolio
  24. 4.4.5 Promensil Recent Developments
  25. 4.5 PhytoLife Pharma
  26. 4.5.1 PhytoLife Pharma Company Information
  27. 4.5.2 PhytoLife Pharma Business Overview
  28. 4.5.3 PhytoLife Pharma Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 PhytoLife Pharma Supplement for Menopause Product Portfolio
  30. 4.5.5 PhytoLife Pharma Recent Developments
  31. 4.6 PharmaLinea
  32. 4.6.1 PharmaLinea Company Information
  33. 4.6.2 PharmaLinea Business Overview
  34. 4.6.3 PharmaLinea Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 PharmaLinea Supplement for Menopause Product Portfolio
  36. 4.6.5 PharmaLinea Recent Developments
  37. 4.7 Otsuka Pharmaceutical
  38. 4.7.1 Otsuka Pharmaceutical Company Information
  39. 4.7.2 Otsuka Pharmaceutical Business Overview
  40. 4.7.3 Otsuka Pharmaceutical Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Otsuka Pharmaceutical Supplement for Menopause Product Portfolio
  42. 4.7.5 Otsuka Pharmaceutical Recent Developments
  43. 4.8 Nordic Naturals
  44. 4.8.1 Nordic Naturals Company Information
  45. 4.8.2 Nordic Naturals Business Overview
  46. 4.8.3 Nordic Naturals Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Nordic Naturals Supplement for Menopause Product Portfolio
  48. 4.8.5 Nordic Naturals Recent Developments
  49. 4.9 New Nordic
  50. 4.9.1 New Nordic Company Information
  51. 4.9.2 New Nordic Business Overview
  52. 4.9.3 New Nordic Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 New Nordic Supplement for Menopause Product Portfolio
  54. 4.9.5 New Nordic Recent Developments
  55. 4.10 Menopace
  56. 4.10.1 Menopace Company Information
  57. 4.10.2 Menopace Business Overview
  58. 4.10.3 Menopace Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Menopace Supplement for Menopause Product Portfolio
  60. 4.10.5 Menopace Recent Developments
  61. 4.11 MenoLabs
  62. 4.11.1 MenoLabs Company Information
  63. 4.11.2 MenoLabs Business Overview
  64. 4.11.3 MenoLabs Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 MenoLabs Supplement for Menopause Product Portfolio
  66. 4.11.5 MenoLabs Recent Developments
  67. 4.12 Menoelle
  68. 4.12.1 Menoelle Company Information
  69. 4.12.2 Menoelle Business Overview
  70. 4.12.3 Menoelle Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Menoelle Supplement for Menopause Product Portfolio
  72. 4.12.5 Menoelle Recent Developments
  73. 4.13 Makers Nutrition
  74. 4.13.1 Makers Nutrition Company Information
  75. 4.13.2 Makers Nutrition Business Overview
  76. 4.13.3 Makers Nutrition Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Makers Nutrition Supplement for Menopause Product Portfolio
  78. 4.13.5 Makers Nutrition Recent Developments
  79. 4.14 Kobayashi Pharmaceutical
  80. 4.14.1 Kobayashi Pharmaceutical Company Information
  81. 4.14.2 Kobayashi Pharmaceutical Business Overview
  82. 4.14.3 Kobayashi Pharmaceutical Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Kobayashi Pharmaceutical Supplement for Menopause Product Portfolio
  84. 4.14.5 Kobayashi Pharmaceutical Recent Developments
  85. 4.15 GNC
  86. 4.15.1 GNC Company Information
  87. 4.15.2 GNC Business Overview
  88. 4.15.3 GNC Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 GNC Supplement for Menopause Product Portfolio
  90. 4.15.5 GNC Recent Developments
  91. 4.16 Flourish
  92. 4.16.1 Flourish Company Information
  93. 4.16.2 Flourish Business Overview
  94. 4.16.3 Flourish Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Flourish Supplement for Menopause Product Portfolio
  96. 4.16.5 Flourish Recent Developments
  97. 4.17 Equelle
  98. 4.17.1 Equelle Company Information
  99. 4.17.2 Equelle Business Overview
  100. 4.17.3 Equelle Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Equelle Supplement for Menopause Product Portfolio
  102. 4.17.5 Equelle Recent Developments
  103. 4.18 Bonafide Health
  104. 4.18.1 Bonafide Health Company Information
  105. 4.18.2 Bonafide Health Business Overview
  106. 4.18.3 Bonafide Health Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bonafide Health Supplement for Menopause Product Portfolio
  108. 4.18.5 Bonafide Health Recent Developments
  109. 4.19 Biofarma Group
  110. 4.19.1 Biofarma Group Company Information
  111. 4.19.2 Biofarma Group Business Overview
  112. 4.19.3 Biofarma Group Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Biofarma Group Supplement for Menopause Product Portfolio
  114. 4.19.5 Biofarma Group Recent Developments
  115. 4.20 Amerifit Brands(Estroven)
  116. 4.20.1 Amerifit Brands(Estroven) Company Information
  117. 4.20.2 Amerifit Brands(Estroven) Business Overview
  118. 4.20.3 Amerifit Brands(Estroven) Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Amerifit Brands(Estroven) Supplement for Menopause Product Portfolio
  120. 4.20.5 Amerifit Brands(Estroven) Recent Developments
  121. 4.21 AdvaCare Pharma
  122. 4.21.1 AdvaCare Pharma Company Information
  123. 4.21.2 AdvaCare Pharma Business Overview
  124. 4.21.3 AdvaCare Pharma Supplement for Menopause Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 AdvaCare Pharma Supplement for Menopause Product Portfolio
  126. 4.21.5 AdvaCare Pharma Recent Developments
5 Global Supplement for Menopause Market Scenario by Region
  1. 5.1 Global Supplement for Menopause Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Supplement for Menopause Sales by Region: 2021-2032
  3. 5.2.1 Global Supplement for Menopause Sales by Region: 2021-2026
  4. 5.2.2 Global Supplement for Menopause Sales by Region: 2027-2032
  5. 5.3 Global Supplement for Menopause Revenue by Region: 2021-2032
  6. 5.3.1 Global Supplement for Menopause Revenue by Region: 2021-2026
  7. 5.3.2 Global Supplement for Menopause Revenue by Region: 2027-2032
  8. 5.4 North America Supplement for Menopause Market Facts & Figures by Country
  9. 5.4.1 North America Supplement for Menopause Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Supplement for Menopause Sales by Country (2021-2032)
  11. 5.4.3 North America Supplement for Menopause Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Supplement for Menopause Market Facts & Figures by Country
  16. 5.5.1 Europe Supplement for Menopause Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Supplement for Menopause Sales by Country (2021-2032)
  18. 5.5.3 Europe Supplement for Menopause Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Supplement for Menopause Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Supplement for Menopause Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Supplement for Menopause Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Supplement for Menopause Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Supplement for Menopause Market Facts & Figures by Country
  41. 5.7.1 South America Supplement for Menopause Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Supplement for Menopause Sales by Country (2021-2032)
  43. 5.7.3 South America Supplement for Menopause Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Supplement for Menopause Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Supplement for Menopause Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Supplement for Menopause Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Supplement for Menopause Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Supplement for Menopause Sales by Type (2021-2032)
  2. 6.1.1 Global Supplement for Menopause Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Supplement for Menopause Sales Market Share by Type (2021-2032)
  4. 6.2 Global Supplement for Menopause Revenue by Type (2021-2032)
  5. 6.2.1 Global Supplement for Menopause Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Supplement for Menopause Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Supplement for Menopause Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Supplement for Menopause Sales by Application (2021-2032)
  2. 7.1.1 Global Supplement for Menopause Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Supplement for Menopause Sales Market Share by Application (2021-2032)
  4. 7.2 Global Supplement for Menopause Revenue by Application (2021-2032)
  5. 7.2.1 Global Supplement for Menopause Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Supplement for Menopause Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Supplement for Menopause Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Supplement for Menopause Value Chain Analysis
  2. 8.1.1 Supplement for Menopause Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Supplement for Menopause Production Mode & Process
  5. 8.2 Supplement for Menopause Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Supplement for Menopause Distributors
  8. 8.2.3 Supplement for Menopause Customers
9 Global Supplement for Menopause Analyzing Market Dynamics
  1. 9.1 Supplement for Menopause Industry Trends
  2. 9.2 Supplement for Menopause Industry Drivers
  3. 9.3 Supplement for Menopause Industry Opportunities and Challenges
  4. 9.4 Supplement for Menopause Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst